CRISPR Therapeutics
CRSP
#3565
Rank
โ‚น369.16 B
Marketcap
โ‚น3,806
Share price
1.43%
Change (1 day)
-22.38%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2026 (TTM): -โ‚น442.18

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น442.95. In 2025 the company made an earnings per share (EPS) of -โ‚น609.29 a decrease over its 2024 EPS that were of -โ‚น408.38.

EPS history for CRISPR Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น442.18-27.43%
2025-โ‚น609.2949.2%
2024-โ‚น408.38
2022-โ‚น782.18-267.74%
2021โ‚น466.32
2019โ‚น103.73-132.36%
2018-โ‚น320.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น126.16-71.52%๐Ÿ‡บ๐Ÿ‡ธ USA